Spojené štáty - angličtina - NLM (National Library of Medicine)

jubilant hollisterstier llc - bassia scoparia pollen (unii: 07a108zkw5) (bassia scoparia pollen - unii:07a108zkw5) - bassia scoparia pollen 0.05 g in 1 ml - allergenic extracts are indicated for use in diagnosis and immunotherapy of patients presenting symptoms of allergy (hay fever, rhinitis, etc.) to specific environmental allergens. the selection of allergenic extracts to be used should be based on a thorough and carefully taken history of hypersensitivity, and confirmed by skin testing. the use of mixed or unrelated antigens for skin testing is not recommended since, in the case of a positive reaction, it does not indicate which component of the mix is responsible for the reaction, while, in the case of a negative reaction, it fails to indicate whether the individual antigens at full concentration would give a positive reaction. utilization of such mixes for compounding a treatment may result, in the former case, in administering unnecessary antigens and, in the latter case, in the omission of a needed antigen. avoidance of allergens is to be advocated if possible, but cannot always be attained, e.g., allergy to dog dander in kennel owners and employees,

Spojené štáty - angličtina - NLM (National Library of Medicine)

jubilant hollisterstier llc - artemisia vulgaris pollen (unii: ant994t71d) (artemisia vulgaris pollen - unii:ant994t71d) - artemisia vulgaris pollen 0.05 g in 1 ml - allergenic extracts are indicated for use in diagnosis and immunotherapy of patients presenting symptoms of allergy (hay fever, rhinitis, etc.) to specific environmental allergens. the selection of allergenic extracts to be used should be based on a thorough and carefully taken history of hypersensitivity, and confirmed by skin testing. the use of mixed or unrelated antigens for skin testing is not recommended since, in the case of a positive reaction, it does not indicate which component of the mix is responsible for the reaction, while, in the case of a negative reaction, it fails to indicate whether the individual antigens at full concentration would give a positive reaction. utilization of such mixes for compounding a treatment may result, in the former case, in administering unnecessary antigens and, in the latter case, in the omission of a needed antigen. avoidance of allergens is to be advocated if possible, but cannot always be attained, e.g., allergy to dog dander in kennel owners and employees,

Spojené štáty - angličtina - NLM (National Library of Medicine)

jubilant hollisterstier llc - chenopodium album pollen (unii: 098lkx5ncn) (chenopodium album pollen - unii:098lkx5ncn) - chenopodium album pollen 0.1 g in 1 ml - allergenic extracts are indicated for use in diagnosis and immunotherapy of patients presenting symptoms of allergy (hay fever, rhinitis, etc.) to specific environmental allergens. the selection of allergenic extracts to be used should be based on a thorough and carefully taken history of hypersensitivity, and confirmed by skin testing. the use of mixed or unrelated antigens for skin testing is not recommended since, in the case of a positive reaction, it does not indicate which component of the mix is responsible for the reaction, while, in the case of a negative reaction, it fails to indicate whether the individual antigens at full concentration would give a positive reaction. utilization of such mixes for compounding a treatment may result, in the former case, in administering unnecessary antigens and, in the latter case, in the omission of a needed antigen. avoidance of allergens is to be advocated if possible, but cannot always be attained, e.g., allergy to dog dander in kennel owners and employees,

Spojené štáty - angličtina - NLM (National Library of Medicine)

jubilant hollisterstier llc - acer negundo pollen (unii: p6k070ar8v) (acer negundo pollen - unii:p6k070ar8v), acer saccharum pollen (unii: v38quq7861) (acer saccharum pollen - unii:v38quq7861), acer rubrum pollen (unii: 700nk45c76) (acer rubrum pollen - unii:700nk45c76) - acer negundo pollen 0.1 g in 1 ml - allergenic extracts are indicated for use in diagnosis and immunotherapy of patients presenting symptoms of allergy (hay fever, rhinitis, etc.) to specific environmental allergens. the selection of allergenic extracts to be used should be based on a thorough and carefully taken history of hypersensitivity, and confirmed by skin testing. the use of mixed or unrelated antigens for skin testing is not recommended since, in the case of a positive reaction, it does not indicate which component of the mix is responsible for the reaction, while, in the case of a negative reaction, it fails to indicate whether the individual antigens at full concentration would give a positive reaction. utilization of such mixes for compounding a treatment may result, in the former case, in administering unnecessary antigens and, in the latter case, in the omission of a needed antigen. avoidance of allergens is to be advocated if possible, but cannot always be attained, e.g., allergy to dog dander in kennel owners and employees,

Spojené štáty - angličtina - NLM (National Library of Medicine)

jubilant hollisterstier llc - liquidambar styraciflua pollen (unii: 5q246ds5bs) (liquidambar styraciflua pollen - unii:5q246ds5bs) - liquidambar styraciflua pollen 0.05 g in 1 ml - allergenic extracts are indicated for use in diagnosis and immunotherapy of patients presenting symptoms of allergy (hay fever, rhinitis, etc.) to specific environmental allergens. the selection of allergenic extracts to be used should be based on a thorough and carefully taken history of hypersensitivity, and confirmed by skin testing. the use of mixed or unrelated antigens for skin testing is not recommended since, in the case of a positive reaction, it does not indicate which component of the mix is responsible for the reaction, while, in the case of a negative reaction, it fails to indicate whether the individual antigens at full concentration would give a positive reaction. utilization of such mixes for compounding a treatment may result, in the former case, in administering unnecessary antigens and, in the latter case, in the omission of a needed antigen. avoidance of allergens is to be advocated if possible, but cannot always be attained, e.g., allergy to dog dander in kennel owners and employees,

Spojené štáty - angličtina - NLM (National Library of Medicine)

jubilant hollisterstier llc - olea europaea pollen (unii: 43r41xz627) (olea europaea pollen - unii:43r41xz627) - olea europaea pollen 0.1 g in 1 ml - allergenic extracts are indicated for use in diagnosis and immunotherapy of patients presenting symptoms of allergy (hay fever, rhinitis, etc.) to specific environmental allergens. the selection of allergenic extracts to be used should be based on a thorough and carefully taken history of hypersensitivity, and confirmed by skin testing. the use of mixed or unrelated antigens for skin testing is not recommended since, in the case of a positive reaction, it does not indicate which component of the mix is responsible for the reaction, while, in the case of a negative reaction, it fails to indicate whether the individual antigens at full concentration would give a positive reaction. utilization of such mixes for compounding a treatment may result, in the former case, in administering unnecessary antigens and, in the latter case, in the omission of a needed antigen. avoidance of allergens is to be advocated if possible, but cannot always be attained, e.g., allergy to dog dander in kennel owners and employees,

Spojené štáty - angličtina - NLM (National Library of Medicine)

nelco laboratories, inc. - paspalum notatum pollen (unii: v003shb7vk) (paspalum notatum pollen - unii:v003shb7vk) - paspalum notatum pollen 10000 [pnu] in 1 ml - allergenic extracts are indicated for use in diagnostic testing and as part of a treatment regime for allergic disease, as established by allergy history and skin test reactivity. allergenic extracts are indicated for the treatment of allergen specific allergic disease for use as hyposensitization or immunotherapy when avoidance of specific allergens can not be attained. the use of allergenic extracts for therapeutic purpose has been established by well-controlled clinical studies. allergenic extracts may be used as adjunctive therapy along with pharmacotherapy which includes antihistamines, corticosteroids, and cromoglycate, and avoidance measures. allergenic extracts for therapeutic use should be given using only the allergen selection to which the patient is allergic, has a history of exposure and are likely to be exposed to again. allergenic extracts should not be used if the patient has asthma, cardiovascular disease, emphysema, diabetes, bleeding diathesis or pregnancy, unless a specific diagnosis of t

Spojené štáty - angličtina - NLM (National Library of Medicine)

greer laboratories, inc. - ambrosia artemisiifolia pollen (unii: k20y81aco3) (ambrosia artemisiifolia pollen - unii:k20y81aco3), ambrosia trifida pollen (unii: ku1v1898xx) (ambrosia trifida pollen - unii:ku1v1898xx) - ambrosia artemisiifolia pollen 0.025 g in 1 ml - short ragweed pollen allergenic extract and short and giant ragweed pollen mix allergenic extract are indicated for: - skin test diagnosis of patients with a clinical history of allergy to ragweed pollen (short ragweed or short and giant ragweed pollen). - immunotherapy for the reduction of ragweed pollen-induced allergic symptoms confirmed by positive skin test or by in vitro testing for pollen-specific ige antibodies for short and/or giant ragweed pollen. short ragweed pollen allergenic extract and short and giant ragweed pollen mix allergenic extract are contraindicated in patients with: - severe, unstable or uncontrolled asthma - history of any severe systemic allergic reaction or any severe local reaction to subcutaneous allergen immunotherapy 8.1 pregnancy risk summary all pregnancies have a risk of birth defect, loss, or other adverse outcomes. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2 to 4% and 15 to

Spojené štáty - angličtina - NLM (National Library of Medicine)

antigen laboratories, inc. - salix lucida ssp. lasiandra pollen (unii: 9p9t267qmr) (salix lucida ssp. lasiandra pollen - unii:9p9t267qmr) - salix lucida ssp. lasiandra pollen 0.05 g in 1 ml - allergenic extract is used for diagnostic testing and for the treatment (immunotherapy) of patients whose histories indicate that upon natural exposure to the allergen, they experience allergic symptoms. confirmation is determined by skin testing. diagnostic use of allergenic extracts usually begins with direct skin testing. this product is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing. do not administer in the presence of diseases characterized by bleeding diathesis. individuals with autoimmune disease may be at risk of exacerbating symptoms of the underlying disease, possibly due to routine immunization. patients who have experienced a recent myocardial infarction may not be tolerant of immunotherapy. children with nephrotic syndrome probably should not receive injections due to immunization causing exacerbation of nephrotic disease.

Kanada - angličtina - Health Canada

alk-abello inc - standardized kentucky blue/june grass pollen - liquid - 100000unit - standardized kentucky blue/june grass pollen 100000unit - allergenic extracts